Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Principles of diagnosis and management of neuroendocrine tumours.

× No keyword cloud information.

66 in total

Review 1. The chromogranin-secretogranin family.

Authors: Laurent Taupenot; Kimberly L Harper; Daniel T O'Connor
Journal: N Engl J Med Date: 2003-03-20 Impact factor: 91.245

2. Life history of the carcinoid tumor of the small intestine.

Authors: C G MOERTEL; W G SAUER; M B DOCKERTY; A H BAGGENSTOSS
Journal: Cancer Date: 1961 Sep-Oct Impact factor: 6.860

3. Gastrointestinal carcinoids: characterization by site of origin and hormone production.

Authors: M W Onaitis; P M Kirshbom; T Z Hayward; F J Quayle; J M Feldman; H F Seigler; D S Tyler
Journal: Ann Surg Date: 2000-10 Impact factor: 12.969

Review 4. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature.

Authors: G Fink; T Krelbaum; A Yellin; D Bendayan; M Saute; M Glazer; M R Kramer
Journal: Chest Date: 2001-06 Impact factor: 9.410

5. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas.

Authors: M A Anderson; S Carpenter; N W Thompson; T T Nostrant; G H Elta; J M Scheiman
Journal: Am J Gastroenterol Date: 2000-09 Impact factor: 10.864

6. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors.

Authors: E Bajetta; L Ferrari; A Martinetti; L Celio; G Procopio; S Artale; N Zilembo; M Di Bartolomeo; E Seregni; E Bombardieri
Journal: Cancer Date: 1999-09-01 Impact factor: 6.860

7. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

Authors: Juan M Sarmiento; Glenroy Heywood; Joseph Rubin; Duane M Ilstrup; David M Nagorney; Florencia G Que
Journal: J Am Coll Surg Date: 2003-07 Impact factor: 6.113

8. Localization of pancreatic endocrine tumors by endoscopic ultrasonography.

Authors: T Rösch; C J Lightdale; J F Botet; G A Boyce; M V Sivak; K Yasuda; N Heyder; L Palazzo; H Dancygier; V Schusdziarra
Journal: N Engl J Med Date: 1992-06-25 Impact factor: 91.245

9. Serum chromogranin A in the diagnosis and follow-up of neuroendocrine tumors of the gastroenteropancreatic tract.

Authors: G Schürmann; U Raeth; B Wiedenmann; H Buhr; C Herfarth
Journal: World J Surg Date: 1992 Jul-Aug Impact factor: 3.352

10. Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor.

Authors: Johanna M Zuetenhorst; Johannes M G M Bonfrer; Catharina M Korse; Rob Bakker; Harm van Tinteren; Babs G Taal
Journal: Cancer Date: 2003-04-01 Impact factor: 6.860

16 in total

1. Meta-Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors.

Authors: Jaume Capdevila; Jorge Hernando; Santiago Perez-Hoyos; Alejandro Roman-Gonzalez; Enrique Grande
Journal: Oncologist Date: 2019-07-22

2. Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study.

Authors: Scott Paulson; David Ray; Sharan Aranha; Amy Scales; Yunfei Wang; Eric Liu
Journal: Oncol Ther Date: 2022-09-22

3. Survival Benefit of Surgical Resection for Pancreatic Neuroendocrine Tumors With Oligometastatic Liver Metastasis: A Retrospective and Propensity Score-Matching Analysis.

Authors: Zhen Yang; Jie Liang; Kaiming Leng; Guangjun Shi
Journal: Front Oncol Date: 2022-06-30 Impact factor: 5.738

4. Bilateral Neuroendocrine Carcinoma of Breast: A Case Report.

Authors: Sulochana Neupane; Sanam Dhakal; Shripad Walawalakar; Surya Bahadur Parajuli; Sulav Sapkota
Journal: JNMA J Nepal Med Assoc Date: 2021-12-11 Impact factor: 0.556

5. Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources.

Authors: Josep Darbà; Alicia Marsà
Journal: BMC Cancer Date: 2019-12-16 Impact factor: 4.430

6. Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review.

Authors: David L Chan; Emily K Bergsland; Jennifer A Chan; Rujuta Gadgil; Thorvardur R Halfdanarson; Kathleen Hornbacker; Virginia Kelly; Pamela L Kunz; Patrick W McGarrah; Nitya P Raj; Diane L Reidy; Alia Thawer; Julia Whitman; Linda Wu; Christoph Becker; Simron Singh
Journal: Oncologist Date: 2021-08-21

Review 7. Opportunities to Improve Symptom Control with Somatostatin Congeners in GEP-NETs: A Review of Key Issues.

Authors: Lowell B Anthony; Thomas M O'Dorisio
Journal: Oncologist Date: 2021-06-18

8. Clinicopathologic analysis of primary gastroenteropancreatic poorly differentiated neuroendocrine carcinoma; A ten year retrospective study of 68 cases at Moffit Cancer Center.

Authors: Mulazim Hussain Bukhari; Domenico Coppola; Aejaz Nasir
Journal: Pak J Med Sci Date: 2020 Jan-Feb Impact factor: 1.088

9. Prognostic significance for colorectal carcinoid tumors based on the 8th edition TNM staging system.

Authors: Piqing Gong; Chunhua Chen; Zhan Wang; Xukun Zhang; Wenxin Hu; Zhiqian Hu; Xinxing Li
Journal: Cancer Med Date: 2020-09-08 Impact factor: 4.452

10. Successful resection of a centrally located primary hepatic neuroendocrine tumor.

Authors: Ahmed Alakeel; Abdullah Alshamrani; Ashwag Alharbi; Alanoud Mubarah; Haider Alshurafa; Meshari Aldayel
Journal: Int J Surg Case Rep Date: 2020-09-30